Rodenstock has unveiled the latest innovations in its ophthalmic lens portfolio in Australia, featuring new B.I.G. NORM lenses that incorporate...
Read moreGlaukos has commenced a Phase 2 clinical program for its third-generation iLink therapy designed to treat keratoconus. The ophthalmic medical...
Read moreAs he calls it a day, CHARLES HORNOR recounts the moment he and Peter Larsen sent an email to Specsavers,...
Read moreMs Cassie Gersbach, a founding member of George and Matilda Eyecare (G&M) who has been with the company for six...
Read moreMany independent optometry practices struggle to convert web browsing consumers into fully fledged customers because their websites are neither optimised...
Read moreFirst developed 30 years ago, Crizal lenses have set the standard of anti-reflection coatings. Essilor has now improved the portfolio...
Read moreThe European Commission (EC) has approved anti-VEGF therapy Beovu (brolucizumab) 6 mg for diabetic macular edema (DME), marking the therapy’s...
Read moreCylite’s vice president of sales and marketing, Ms Kylee Hall, has taken over as CEO from the company’s founder and...
Read morePrivate health provider SMS Healthcare has expanded its ophthalmology portfolio with the addition of LASERSIGHT Australia's five-clinic refractive eye surgery...
Read moreA patient arrives for a scheduled eye procedure, to be performed under sedation. They plan to take the train home...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited